However, unlike the benefit of supplemental insulin treatment in individuals with diabetes with insulin resistance, leptin treatment had little or no effect to reduce obesity in the general population, and thus the strategy was quickly abandoned (6). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.